KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) FCF Margin (2017 - 2025)

Historic FCF Margin for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to 80.09%.

  • Bionano Genomics' FCF Margin rose 1390600.0% to 80.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 65.13%, marking a year-over-year increase of 2140000.0%. This contributed to the annual value of 224.28% for FY2024, which is 1270100.0% up from last year.
  • As of Q3 2025, Bionano Genomics' FCF Margin stood at 80.09%, which was up 1390600.0% from 51.98% recorded in Q2 2025.
  • Over the past 5 years, Bionano Genomics' FCF Margin peaked at 43.36% during Q1 2025, and registered a low of 585.08% during Q1 2022.
  • Its 5-year average for FCF Margin is 314.21%, with a median of 322.07% in 2021.
  • Per our database at Business Quant, Bionano Genomics' FCF Margin surged by 2885900bps in 2021 and then plummeted by -1461900bps in 2022.
  • Over the past 5 years, Bionano Genomics' FCF Margin (Quarter) stood at 416.69% in 2021, then fell by -5bps to 439.05% in 2022, then surged by 35bps to 284.71% in 2023, then surged by 72bps to 79.68% in 2024, then decreased by -1bps to 80.09% in 2025.
  • Its FCF Margin was 80.09% in Q3 2025, compared to 51.98% in Q2 2025 and 43.36% in Q1 2025.